India wants price controls on cancer generics

India's National Pharmaceutical Pricing Authority ( NPPA) requested pricing information on generic cancer drugs from six

Read the full 162 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE